Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

25-(OH)D, 25-hydroxyvitamin D; CI, confidence interval; FDR, false discovery rate.

Source: Change in 25-(OH)D. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Association of caffeine citrate plus vitamin A/D drops with bronchopulmonary dysplasia and respiratory outcomes in preterm infants born at <32 weeks’ gestation: a 72-h landmark retrospective cohort study

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of caffeine citrate plus vitamin A/D drops with bronchopulmonary dysplasia and respiratory outcomes in preterm infants born at

Cohort study · Frontiers in Pediatrics · 2026

Original publication title

Association of caffeine citrate plus vitamin A/D drops with bronchopulmonary dysplasia and respiratory outcomes in preterm infants born at

Rongying Su; Yaohua Pei

© 2026 Su and Pei.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Among infants who survived to 72 h, early initiation of vitamin A/D drops as an adjunct to caffeine was associated with lower risks of BPD and death or BPD, as well as more favorable short-term respiratory outcomes. Non-randomized treatment allocation, complete-case selection, and residual confounding preclude causal inference.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

The aim of this work is to examine whether the early addition of vitamin A/D drops to caffeine citrate was associated with bronchopulmonary dysplasia (BPD) and short-term respiratory outcomes in preterm infants born at <32 weeks’ gestation.

Source: Objective

Abstract: What methods does the paper describe?

This single-center, 72-h landmark retrospective cohort study included 126 infants admitted to the hospital between October 2022 and November 2024 with a gestational age <32 weeks and birth weight ≤1.5 kg. Exposure was determined at 72 h as either caffeine alone or caffeine plus vitamin A/D drops. Complete-case analyses were performed. Among the 119 infants who survived to 36 weeks’ postmenstrual age, BPD, longitudinal outcomes, and clinical course were evaluated. Multivariable regression and stabilized inverse probability of treatment weighting (IPTW) were applied.

Source: Methods

Abstract: Results

BPD occurred in 20 of 55 survivors (36.4%) receiving caffeine alone and 11 of 64 (17.2%) receiving combination therapy. After adjustment for gestational age, birth weight, and grade III: IV respiratory distress syndrome, combination therapy was associated with a lower risk of BPD [adjusted odds ratio (aOR), 0.36; 95% confidence interval (CI), 0.14 to 0.90]. The composite outcome of death or BPD occurred in 25 of 60 infants (41.7%) in the caffeine group and 13 of 66 (19.7%) in the combination group (extended-model aOR, 0.33; 95% CI, 0.14 to 0.80); IPTW results were consistent.

Combination therapy was also associated with more favorable changes in blood gas and inflammatory markers, along with shorter durations of respiratory support and hospitalization. No serious adverse event required permanent treatment discontinuation.

Source: Results

Abstract: Conclusion

Among infants who survived to 72 h, early initiation of vitamin A/D drops as an adjunct to caffeine was associated with lower risks of BPD and death or BPD, as well as more favorable short-term respiratory outcomes. Non-randomized treatment allocation, complete-case selection, and residual confounding preclude causal inference.

Source: Conclusion
Authors’ abstract

Objective

The aim of this work is to examine whether the early addition of vitamin A/D drops to caffeine citrate was associated with bronchopulmonary dysplasia (BPD) and short-term respiratory outcomes in preterm infants born at <32 weeks’ gestation.

Methods

This single-center, 72-h landmark retrospective cohort study included 126 infants admitted to the hospital between October 2022 and November 2024 with a gestational age <32 weeks and birth weight ≤1.5 kg. Exposure was determined at 72 h as either caffeine alone or caffeine plus vitamin A/D drops. Complete-case analyses were performed. Among the 119 infants who survived to 36 weeks’ postmenstrual age, BPD, longitudinal outcomes, and clinical course were evaluated. Multivariable regression and stabilized inverse probability of treatment weighting (IPTW) were applied.

Results

BPD occurred in 20 of 55 survivors (36.4%) receiving caffeine alone and 11 of 64 (17.2%) receiving combination therapy. After adjustment for gestational age, birth weight, and grade III: IV respiratory distress syndrome, combination therapy was associated with a lower risk of BPD [adjusted odds ratio (aOR), 0.36; 95% confidence interval (CI), 0.14 to 0.90]. The composite outcome of death or BPD occurred in 25 of 60 infants (41.7%) in the caffeine group and 13 of 66 (19.7%) in the combination group (extended-model aOR, 0.33; 95% CI, 0.14 to 0.80); IPTW results were consistent.

Combination therapy was also associated with more favorable changes in blood gas and inflammatory markers, along with shorter durations of respiratory support and hospitalization. No serious adverse event required permanent treatment discontinuation.

Conclusion

Among infants who survived to 72 h, early initiation of vitamin A/D drops as an adjunct to caffeine was associated with lower risks of BPD and death or BPD, as well as more favorable short-term respiratory outcomes. Non-randomized treatment allocation, complete-case selection, and residual confounding preclude causal inference.

Publication and source details

Original title: Association of caffeine citrate plus vitamin A/D drops with bronchopulmonary dysplasia and respiratory outcomes in preterm infants born at

Rongying Su; Yaohua Pei

Frontiers in Pediatrics · 2026

* Correspondence: Yaohua Pei A13303217691@outlook.com© 2026 Su and Pei.2026Su and Peihttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:49:21.373599+00:00

DOI: 10.3389/fped.2026.1923440 · PMC13553532